US FDA reverses course, will review Moderna’s flu vaccine application
Dr. Jesse Goodman, former FDA chief scientist, called the approach the agency finally settled on very sensible, but said it was a "really badly done process" to get there. If…
Dr. Jesse Goodman, former FDA chief scientist, called the approach the agency finally settled on very sensible, but said it was a "really badly done process" to get there. If…